Looking back on the COVID-19 pandemic 3 years later: Has the virus won? The virus appears here to stay, along with the threat of a more dangerous version sweeping the planet. (Associated Press)
Moderna said it plans to hire 2,000 new employees by the end of 2023 and expand its U.S. presence on the West Coast. The drugmaker plans to open new offices in California and Seattle. (Reuters)
Novartis CEO Vas Narasimhan brought home 8.4 million Swiss francs ($9 million) in 2022, which was a 25% decrease from the year prior. Narasimhan did not hit certain performance metrics, including meeting his 24.8% goal of group free cash flow as a percent of sales, as Novartis has undergone a restructuring with layoffs. (Endpoints News)
The House of Representatives passed a bill Friday that would require the Director of National Intelligence to declassify information on how the COVID-19 virus originated. If the bill is signed into law, it would require White House officials to send an unclassified report to Congress within 90 days, though it’s unclear how much the information would illuminate on the issue. (Axios)
Eli Lilly Alzheimer’s treatment solanezumab failed to slow disease progression. Solanezumab’s failure is a blow to efforts to treat Alzheimer’s in people who are in the very early stage of the disease and have not yet shown clinical symptoms. (CNBC)
